Search research articles
Contact Us
Filters
Showing results (41-50 of 201) with videos related to
Page
of 21
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 12, 2009
Treatment of HBeAg-positive patients with nucleos/tide analogues
Carla S Coffin, Samuel S Lee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
November 8, 2013
Liver transplantation for alcoholic liver disease: a devilish dilemma
Stephen E Congly, Samuel S Lee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
June 22, 2012
Hepatitis C, insulin resistance and fatty liver: bad things come in threes
Ayman A Abdo, Samuel S Lee
Gastroenterologie Clinique Et Biologique
|
November 16, 2002
Cirrhotic cardiomyopathy
Hongqun Liu, Daisheng Song, Samuel S Lee
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 7, 2011
Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies
Kally Cheung, Samuel S Lee, Maitreyi Raman
Biomedicines
|
July 29, 2023
Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy
Sang Youn Hwang, Hongqun Liu, Samuel S Lee
Alimentary Pharmacology & Therapeutics
|
February 18, 2025
Letter: Lubiprostone-A Novel Therapeutic Avenue for Gastrointestinal Complications in MASLD. Authors' Reply
Mohamed El-Kassas, Hongqun Liu, Samuel S Lee
Hepatobiliary Surgery and Nutrition
|
September 2, 2025
Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition
Mohamed El-Kassas, Hongqun Liu, Samuel S Lee
Current Vascular Pharmacology
|
August 5, 2008
Amiodarone hepatotoxicity
Mohamed Babatin, Samuel S Lee, P Timothy Pollak
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 16, 2008
Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis
Leila Moezi, Seyed Ali Gaskari, Samuel S Lee
Page
of 21
Search research articles
Search
Showing results (41-50 of 201) with videos related to
Sort By:
Page
of 21
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 12, 2009
Treatment of HBeAg-positive patients with nucleos/tide analogues
Carla S Coffin, Samuel S Lee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
November 8, 2013
Liver transplantation for alcoholic liver disease: a devilish dilemma
Stephen E Congly, Samuel S Lee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
June 22, 2012
Hepatitis C, insulin resistance and fatty liver: bad things come in threes
Ayman A Abdo, Samuel S Lee
Gastroenterologie Clinique Et Biologique
|
November 16, 2002
Cirrhotic cardiomyopathy
Hongqun Liu, Daisheng Song, Samuel S Lee
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 7, 2011
Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies
Kally Cheung, Samuel S Lee, Maitreyi Raman
Biomedicines
|
July 29, 2023
Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy
Sang Youn Hwang, Hongqun Liu, Samuel S Lee
Alimentary Pharmacology & Therapeutics
|
February 18, 2025
Letter: Lubiprostone-A Novel Therapeutic Avenue for Gastrointestinal Complications in MASLD. Authors' Reply
Mohamed El-Kassas, Hongqun Liu, Samuel S Lee
Hepatobiliary Surgery and Nutrition
|
September 2, 2025
Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition
Mohamed El-Kassas, Hongqun Liu, Samuel S Lee
Current Vascular Pharmacology
|
August 5, 2008
Amiodarone hepatotoxicity
Mohamed Babatin, Samuel S Lee, P Timothy Pollak
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 16, 2008
Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis
Leila Moezi, Seyed Ali Gaskari, Samuel S Lee
Page
of 21